SAN JOSE, CALIF.—Pharmaceutical company Pfizer announced its development of “Paxlovid,” a COVID-19 pill claiming to dramatically cut the risks of symptoms in later COVID-19 stages by 89% on Nov. 5, 2021.  Simply […]